Bayer AG (BAYZF)
56.34
+0.74
(+1.33%)
USD |
OTCM |
Jun 02, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 55.35B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -17.26% |
| Valuation | |
| PE Ratio | 17.27 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 1.050 |
| Price to Book Value | 1.242 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 2.633 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.00 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 61.74% |
Profile
| Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto. |
| URL | http://www.bayer.com |
| Investor Relations URL | N/A |
| HQ State/Province | N/A |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Equity Style | Large Cap/Value |
| Next Earnings Release | Aug. 04, 2023 (est.) |
| Last Earnings Release | May. 11, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | May. 02, 2023 |
Ratings
Profile
| Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto. |
| URL | http://www.bayer.com |
| Investor Relations URL | N/A |
| HQ State/Province | N/A |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Equity Style | Large Cap/Value |
| Next Earnings Release | Aug. 04, 2023 (est.) |
| Last Earnings Release | May. 11, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | May. 02, 2023 |